Drug delivery platforms
Hovione has unique capabilities and expertise in solubility enhancement, lung delivery, modified release and taste-masking applications.
Employing several innovative platform technologies particles can now be engineered to provide an: improvement in oral bioavailability, patient acceptability or to provide for modified release or enhanced delivery. Hovione can also offer customized Particle Engineering services to meet your development needs.
Overcoming poor bioavailability through amorphous solid dispersions
Amorphous solid dispersions are a proven platform to overcome the poor solubility of BCS class II drugs.
http://go.hovione.com/l/47122/2014-07-29/7pw3